Anthony William Tolcher
Oprichter bij South Texas Accelerated Research Therapeutics LLC
Actieve functies van Anthony William Tolcher
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
South Texas Accelerated Research Therapeutics LLC
 South Texas Accelerated Research Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services South Texas Accelerated Research Therapeutics LLC is a global phase research organization focused on accelerating the development of new anticancer drugs with the purpose of improving life and survival of patients with cancer. The company was founded by Anthony W. Tolcher, Amita Patnaik and Kyriakos P. Papadopoulos and is headquartered in San Antonio, TX. | Oprichter | 01-01-2007 | - |
| President | 01-01-2007 | - | |
| Corporate Officer/Principal | 01-01-2007 | 01-01-2007 |
Loopbaan van Anthony William Tolcher
Eerdere bekende functies van Anthony William Tolcher
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| American Association of Clinical Oncology | Voorzitter | - | - |
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Directeur/Bestuurslid | 19-05-2017 | - |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Directeur/Bestuurslid | - | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Denemarken | 2 |
| Canada | 2 |
Operationeel
| Director/Board Member | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
South Texas Accelerated Research Therapeutics LLC
South Texas Accelerated Research Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services South Texas Accelerated Research Therapeutics LLC is a global phase research organization focused on accelerating the development of new anticancer drugs with the purpose of improving life and survival of patients with cancer. The company was founded by Anthony W. Tolcher, Amita Patnaik and Kyriakos P. Papadopoulos and is headquartered in San Antonio, TX. | Commercial Services |
| American Association of Clinical Oncology | |
Bristol-Myers Squibb FCT bêta, Inc.
Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Health Technology |
